International
The Morning Science

What science found today

‹
 

Business

China’s rapid growth in early-stage pharma rattles US

C&EN · By Umair Irfan ·

The Brief

  • China is seeing a large increase in drug investment, drug discovery and clinical trials.
  • The US faces research cuts, according to the source article.
  • The source reports this shift in early-stage pharmaceutical research as a source of concern in the US.

Why it matters

Shifts in where early-stage drug research and clinical trials happen can affect the pace of new medicines, research funding decisions and international collaboration in pharmaceutical science.

Who’s affected

  • pharmaceutical researchers
  • science policy analysts
  • US research funding stakeholders

China is seeing a huge increase in drug investment, discovery, and clinical trials while the US faces research cuts

How do you feel about this?

0 Comments

    China’s rapid growth in early-stage pharma rattles US – The Morning Science